202 related articles for article (PubMed ID: 2826819)
1. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.
Thiesen HJ; Bösze Z; Henry L; Charnay P
J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819
[TBL] [Abstract][Full Text] [Related]
2. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
[TBL] [Abstract][Full Text] [Related]
3. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
Golemis E; Li Y; Fredrickson TN; Hartley JW; Hopkins N
J Virol; 1989 Jan; 63(1):328-37. PubMed ID: 2783259
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
Manley NR; O'Connell MA; Sharp PA; Hopkins N
J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
[TBL] [Abstract][Full Text] [Related]
5. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus.
Bösze Z; Thiesen HJ; Charnay P
EMBO J; 1986 Jul; 5(7):1615-23. PubMed ID: 3462001
[TBL] [Abstract][Full Text] [Related]
6. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.
Li Y; Golemis E; Hartley JW; Hopkins N
J Virol; 1987 Mar; 61(3):693-700. PubMed ID: 3468264
[TBL] [Abstract][Full Text] [Related]
7. A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.
Chatis PA; Holland CA; Silver JE; Frederickson TN; Hopkins N; Hartley JW
J Virol; 1984 Oct; 52(1):248-54. PubMed ID: 6090701
[TBL] [Abstract][Full Text] [Related]
8. Study of the 78A1 isolate of Moloney murine sarcoma virus. I. Molecular cloning and characterization.
Devaux J; Jouanneau J; Quibriac M; Longuet M; Le Bousse-Kerdiles MC; Auger-Buendia MA; Tavitian A
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2407-14. PubMed ID: 2997374
[TBL] [Abstract][Full Text] [Related]
9. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus.
Stocking C; Kollek R; Bergholz U; Ostertag W
Virology; 1986 Aug; 153(1):145-9. PubMed ID: 3016984
[TBL] [Abstract][Full Text] [Related]
10. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.
Manley NR; O'Connell M; Sun W; Speck NA; Hopkins N
J Virol; 1993 Apr; 67(4):1967-75. PubMed ID: 8445718
[TBL] [Abstract][Full Text] [Related]
11. Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis.
Stacey A; Arbuthnott C; Kollek R; Coggins L; Ostertag W
J Virol; 1984 Jun; 50(3):725-32. PubMed ID: 6328002
[TBL] [Abstract][Full Text] [Related]
12. Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the psi-gag-PR region.
Richardson J; Corbin A; Pozo F; Orsoni S; Sitbon M
J Virol; 1993 Sep; 67(9):5478-86. PubMed ID: 8350407
[TBL] [Abstract][Full Text] [Related]
13. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
14. Mutational analyses of the Moloney murine sarcoma virus enhancer.
Schulze F; Boehnlein E; Gruss P
DNA; 1985 Jun; 4(3):193-202. PubMed ID: 2988891
[TBL] [Abstract][Full Text] [Related]
15. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
[TBL] [Abstract][Full Text] [Related]
16. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses.
Vogt M; Haggblom C; Swift S; Haas M
J Virol; 1985 Jul; 55(1):184-92. PubMed ID: 4009793
[TBL] [Abstract][Full Text] [Related]
17. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
Fan H; Chute H; Chao E; Pattengale PK
Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
[TBL] [Abstract][Full Text] [Related]
18. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
Granger SW; Fan H
J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
[TBL] [Abstract][Full Text] [Related]
19. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
Baum C; Eckert HG; Stocking C; Ostertag W
Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
[TBL] [Abstract][Full Text] [Related]
20. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
Chatis PA; Holland CA; Hartley JW; Rowe WP; Hopkins N
Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4408-11. PubMed ID: 6308622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
